Live updates

Griff Rhys Jones withdraws from Cardiff University role

The comedian has withdrawn from becoming the university's Chancellor Credit: ITV Cymru Wales

Griff Rhys Jones has withdrawn from becoming Cardiff University's new Chancellor just two weeks after an embarrassing debacle which saw his appointment halted at the last minute.

The comedian's appointment was blocked when it emerged current chancellor Sir Martin Evans was not offered the chance to be reappointed.

In a letter to the Vice Chancellor, Professor Colin Riordan, Jones said: "Following the recent decision of the Court of Cardiff University to refer the appointment of a new Chancellor back to the Council, I can see that it is going to need a period of reconsideration and re-evaluation.

"It may well be that the Council wants to re-offer the post to the incumbent, Sir Martin Evans. Sir Martin may decide to take it or step aside.

"I feel, however, that my presence only makes this a more complicated process for everyone concerned. I believe it better that I should withdraw.

"I can't say that I am offering my resignation. I haven't yet been appointed. But I do not want to be further considered for this post. I was honoured to be chosen."

A spokesperson for Cardiff University said: "Cardiff University is very sorry for creating the circumstances that led Griff Rhys Jones to step aside. These events were based solely on internal rules and procedures: our ongoing friendship with Griff Rhys Jones was never in question.

"We are immensely proud of Griff’s continuing work as an Honorary Fellow and Patron to our Sustainable Places Research Institute, and he remains a trusted supporter of the University.

"Council will meet to consider the nomination of a future Chancellor at a meeting on 19 May. Professor Sir Martin Evans has indicated to the Chair of Council his willingness to be considered for nomination for a further term.”

Cardiff University leads new global Alzheimer's research

Scientists from Cardiff University are leading new global research into Alzheimer's disease, in a study involving more than one million people around the world.

The £6m project will look into the relationship between genetics and lifestyle in the development of Alzheimer's, hoping to produce the most comprehensive understanding of the disease's risk to date.

Cardiff University's Professor Julie Williams is leading the global research.

"For too long scientists studying Alzheimer's have been working in silos, engaged in a single-minded 'race' to try and beat the disease. That's simply not going to happen unless we pull together," said Principal Investigator Prof Julie Williams from Cardiff University.

"The insights gleaned will pave the way for a new era of therapies. We predict that in future, based on this unrivalled data, GPs may be able run a simple test to analyse a patient's risk of developing Alzheimer's."

"A combination of gene therapy, drugs and lifestyle changes could then be prescribed to reduce that risk."

The research will look at the genetic data of more than a million people over the age of 65, from Europe, America, Australia and Asia.


Cardiff medical students to train in the community

The new programme at Cardiff will mean students working in the community. Credit: ITV News

Cardiff has unveiled a new approach to training and retaining doctors in Wales.

Marking the biggest transformation of Cardiff University's medical education programme since its School of Medicine was founded in 1921 the new curriculum aims to cultivate world-class doctors by introducing more community centred learning.

Studies show that medical students who train in underserved areas are more likely to return there to work after graduation.

Professor John Bligh, Dean of Cardiff University's School of Medicine said:

One students learns how to take a blood sample. Credit: ITV News

"Ultimately our goal is to modernise teaching with a view to producing world-class clinicians who want to live and work in Wales for the benefit of Welsh patients, and we hope the community-centred learning experience that this curriculum offers will encourage this."

Under the new curriculum, students will be introduced to community-based learning in their first year to ensure early patient contact. Cardiff University School of Medicine is responsible for the graduation of 300 student doctors annually.


New curriculum to change doctor training in Wales

A new education programme launched by Cardiff University's School of Medicine aims to transform the way doctors are trained and produce more doctors 'who want to live and work in Wales'.

The new curriculum is an important milestone for medical education in Wales and will play a critical role in ensuring the future health of Wales.

Not only will it encourage students to be independent, life-long learners with a strong focus on science within clinical practice, but it will also instil at the heart of their learning, a renewed patient consciousness.

Ultimately, our goal is to modernise teaching with a view to producing world-class clinicians who want to live and work in Wales for the benefit of Welsh patients, and we hope the community-centred learning experience that this curriculum offers will encourage this.

– Professor John Bligh, Dean of Cardiff University's School of Medicine

Education programme to train and keep doctors in Wales

The new programme aims to produce first-rate patients care and change the way doctors are trained. Credit: PA

Wales' largest medical school has unveiled a new education programme designed to attract, train and retain the best doctors for the country.

Cardiff University's School of Medicine will launch a new undergraduate patient-focused curriculum to transform the way doctors are trained.

Under the new curriculum, aspiring doctors will visit patients at home and learn about clinical consulting from GP tutors in their surgeries.

Scientists develop drug to stop breast cancer spread

Cardiff scientists are developing a drug to tackle metastatic tumours Credit: ITV Cymru Wales

Scientists at Cardiff University have developed an experimental compound that can reduce the spread of breast cancer by more than eighty percent.

Up to 12,000 women a year develop these additional tumours.

This new approach of tackling the disease through drugs is in the pre clinical phase. Researchers are now working to prepare the drug for patient trials in the next 18 months.

Load more updates